NVNO enVVeno Medical Corporation
-
enVVeno Medical Reported Earnings
Thursday, July 30, 2026 · 12:00 AM ET
enVVeno Medical (NVNO) reported a loss of $5.37 per share on revenue of $0.00 million for the second quarter ended June 2026. .
enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($5.37)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—